AMETEK (NYSE:AME) Receives Buy Rating from DA Davidson

AMETEK (NYSE:AME)‘s stock had its “buy” rating reiterated by analysts at DA Davidson in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $240.00 price objective on the technology company’s stock. DA Davidson’s price target would indicate a potential upside of 5.39% from the company’s previous close.

AME has been the subject of several other reports. Weiss Ratings reaffirmed a “buy (b)” rating on shares of AMETEK in a research note on Wednesday, January 21st. Truist Financial set a $265.00 price objective on AMETEK in a research note on Wednesday. Melius Research set a $235.00 price objective on shares of AMETEK in a report on Monday, January 5th. Deutsche Bank Aktiengesellschaft assumed coverage on shares of AMETEK in a report on Wednesday, January 21st. They set a “buy” rating and a $271.00 price target on the stock. Finally, Robert W. Baird increased their price target on AMETEK from $198.00 to $204.00 and gave the company a “neutral” rating in a research report on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $239.27.

AMETEK Trading Down 0.5%

Shares of AME traded down $1.19 during mid-day trading on Wednesday, reaching $227.73. 2,259,676 shares of the company were exchanged, compared to its average volume of 1,401,926. The business has a 50 day simple moving average of $209.02 and a two-hundred day simple moving average of $194.83. AMETEK has a 52 week low of $145.02 and a 52 week high of $234.56. The stock has a market capitalization of $52.42 billion, a PE ratio of 35.92, a PEG ratio of 3.10 and a beta of 1.03. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.72 and a current ratio of 1.16.

AMETEK (NYSE:AME) last posted its quarterly earnings data on Tuesday, February 3rd. The technology company reported $2.01 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.07. AMETEK had a net margin of 20.50% and a return on equity of 16.66%. The company had revenue of $2 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same period in the prior year, the company posted $1.87 earnings per share. AMETEK’s revenue for the quarter was up 13.4% compared to the same quarter last year. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. On average, analysts predict that AMETEK will post 7.15 earnings per share for the current fiscal year.

Insider Activity at AMETEK

In other AMETEK news, CEO David A. Zapico sold 88,000 shares of the business’s stock in a transaction on Tuesday, November 25th. The shares were sold at an average price of $196.39, for a total transaction of $17,282,320.00. Following the transaction, the chief executive officer directly owned 348,955 shares of the company’s stock, valued at approximately $68,531,272.45. The trade was a 20.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Thomas C. Marecic sold 14,310 shares of AMETEK stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $202.11, for a total transaction of $2,892,194.10. Following the transaction, the insider directly owned 42,589 shares of the company’s stock, valued at approximately $8,607,662.79. This trade represents a 25.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 137,088 shares of company stock worth $27,212,340 in the last 90 days. Company insiders own 0.57% of the company’s stock.

Institutional Investors Weigh In On AMETEK

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Darwin Wealth Management LLC purchased a new stake in shares of AMETEK in the second quarter worth about $25,000. CoreCap Advisors LLC grew its stake in AMETEK by 84.3% in the 4th quarter. CoreCap Advisors LLC now owns 129 shares of the technology company’s stock worth $26,000 after acquiring an additional 59 shares in the last quarter. BOKF NA increased its position in shares of AMETEK by 137.7% during the fourth quarter. BOKF NA now owns 145 shares of the technology company’s stock worth $30,000 after acquiring an additional 84 shares during the period. NewSquare Capital LLC increased its holdings in AMETEK by 129.7% during the 2nd quarter. NewSquare Capital LLC now owns 170 shares of the technology company’s stock worth $31,000 after purchasing an additional 96 shares during the period. Finally, TruNorth Capital Management LLC bought a new stake in AMETEK during the 3rd quarter valued at $31,000. 87.43% of the stock is owned by hedge funds and other institutional investors.

Key AMETEK News

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Q4 results beat estimates and revenue grew 13.4% Y/Y — AME reported $2.01 EPS vs. $1.94 consensus and record quarterly and full‑year revenue, driven by broad strength across both operating segments, supporting the company’s growth narrative. Read More.
• Positive Sentiment: Analyst upgrade — KeyCorp raised its price target to $260 and kept an Overweight rating, signaling bullish analyst sentiment and implying material upside from current levels. Read More.
• Positive Sentiment: Strategic tuck‑in acquisition — AMETEK agreed to acquire LKC Technologies (visual electrophysiology/ophthalmic diagnostics), expanding its healthcare/medical instruments exposure and adding product diversification. Read More.
• Neutral Sentiment: 2026 guidance essentially in line but slightly cautious — AME set FY26 EPS at $7.870–8.070 (vs. ~8.00 consensus) and Q1 EPS at $1.85–1.90 (vs. ~1.90 consensus). The guidance is mostly consistent with current expectations but leaves limited upside, which tempers the beat. Read More.
• Negative Sentiment: Analyst caution persists — Morgan Stanley kept a Hold rating with a $215 target, highlighting margin and valuation caution despite resilient revenue trends; mixed analyst views add short‑term volatility risk. Read More.
• Negative Sentiment: Valuation/upgrade risk commentary — Some research notes (e.g., Seeking Alpha) warn AMETEK’s rich valuation could lead to downgrades if margins or growth decelerate, which can pressure the stock despite strong results. Read More.
• Negative Sentiment: Tariff uncertainty flagged — Management flagged tariff-related risks that could depress 2026 profit versus some estimates, a direct near‑term headwind to guidance clarity. Read More.

About AMETEK

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.